Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Adamas Pharma (NQ: ADMS)
19.17 USD  -0.51 (-2.59%)
Official Closing Price  /  Updated: 4:41 PM EDT, Sep 21, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,430,300
Open 19.71
Bid (Size) 19.05 (2)
Ask (Size) 19.80 (5)
Prev. Close 19.68
Today's Range 18.94 - 20.09
52wk Range 17.68 - 44.00
Shares Outstanding 26,982,322
Dividend Yield N/A
Performance
YTD
-46.23%
-46.23%
1 Month
-12.06%
-12.06%
3 Month
-21.24%
-21.24%
6 Month
-21.43%
-21.43%
1 Year
-9.75%
-9.75%
Top News
More News
Adamas Announces New Employment Inducement Grant
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted six new employees the option to purchase an aggregate of 68,251... Read More
from GlobeNewswire News Releases
Investor Expectations to Drive Momentum within Mazor Robotics, Kinross Gold, Mimecast, DBV Technologies S.A., Adamas Pharmaceuticals, and Adverum Biotechnologies — Discovering Underlying Factors of In
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Mazor Robotics Ltd.... Read More
from GlobeNewswire News Releases
More News
Read More
Adamas Announces New Employment Inducement Grant
from GlobeNewswire News Releases
Global Advanced Distributed Management System (ADMS) Market 2018 Analysis, Opportunities and Growth, Forecast to 2025
category Europe , Africa , Press Release , and 11 more.
from iCrowdNewswire
Global Advanced Distributed Management System (ADMS) Market 2018 Analysis, Opportunities and Growth, Forecast to 2025
category North America , Press Release , English , and 11 more.
from iCrowdNewswire
Adamas Reports Second Quarter 2018 Financial Results
from GlobeNewswire News Releases
Adamas Pharmaceuticals Launches “Dyskinesia Is A Jerk™,” a Campaign to Raise Awareness and Highlight the Impact of Parkinson’s Disease Dyskinesia
from GlobeNewswire News Releases
IEIH's Holdings Could Mean 13% Gain Potential
category ETFs
from ETF Channel
First Week of October 19th Options Trading For Adamas Pharmaceuticals (ADMS)
category Stocks
from Market News Video
Notable Friday Option Activity: ADMS, POST, AAOI
category Stocks
from Market News Video
Bullish Two Hundred Day Moving Average Cross - ADMS
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.